Silo Pharma Inc (SILO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,580 | -1,919 | -906 | -3,909 | -2,246 |
| Depreciation Amortization | 90 | 68 | 34 | N/A | N/A |
| Accounts receivable | -4 | -2 | -1 | -5 | -4 |
| Accounts payable and accrued liabilities | N/A | N/A | N/A | N/A | 16 |
| Other Working Capital | 155 | 595 | 176 | -75 | -717 |
| Other Operating Activity | 23 | 16 | 5 | 491 | 339 |
| Operating Cash Flow | $-2,315 | $-1,243 | $-693 | $-3,498 | $-2,612 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 1,891 | 518 | N/A | 67 | N/A |
| Purchase Of Investment | -10,467 | -10,352 | -6,008 | N/A | 67 |
| Other Investing Activity | 0 | 0 | 0 | 20 | 20 |
| Investing Cash Flow | $-8,576 | $-9,835 | $-6,008 | $87 | $87 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | N/A | N/A | 4,941 | 4,941 |
| Common Stock Repurchased | -277 | -131 | N/A | N/A | N/A |
| Financing Cash Flow | $-277 | $-131 | $N/A | $4,941 | $4,941 |
| Beginning Cash Position | 11,367 | 11,367 | 11,367 | 9,837 | 9,837 |
| End Cash Position | 200 | 159 | 4,666 | 11,367 | 12,253 |
| Net Cash Flow | $-11,167 | $-11,208 | $-6,701 | $1,530 | $2,416 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,315 | -1,243 | -693 | -3,498 | -2,612 |
| Free Cash Flow | -2,315 | -1,243 | -693 | -3,498 | -2,612 |